ReviewBMJ (Clinical research ed.)2014
Subjects no more: what happens when trial participants realize they hold the power?
Review in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Trial
- Article
- So You Want to Build Your Disease's First Online Patient Registry: An Educational Guide for Patient Organizations Based on US and European Experience.The patient · 2023Article
- Feasibility and Efficacy of Online Strategies to Recruit Parents of Children With Rheumatic Diseases for Research.ACR open rheumatology · 2022Article
- Article
- Blinding in Clinical Trials: Seeing the Big Picture.Medicina (Kaunas, Lithuania) · 2021Review
- Clinical Trials in the Era of Digital Engagement: A SWOG Call to Action.JCO clinical cancer informatics · 2020Article
- "Hunting Down My Son's Killer": New Roles of Patients in Treatment Discovery and Ethical Uncertainty.Journal of bioethical inquiry · 2020Article
- No other interest can take precedence - a patient's perspective on oncology drug development.Nature reviews. Clinical oncology · 2019Article
- A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.Journal of medical Internet research · 2019Article
- Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.Journal of Huntington's disease · 2019Article
- Patient, study thyself.BMC medicine · 2018Article
- The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study.Journal of medical Internet research · 2018Article
- Information and Communication Technologies, Genes, and Peer-Production of Knowledge to Empower Citizens' Health.Science and engineering ethics · 2018Article
- Marking 15 years of the Genetic and Rare Diseases Information Center.Translational science of rare diseases · 2017Article
- Open sharing of genomic data: Who does it and why?PloS one · 2017Article
- Culture and Process Change as a Priority for Patient Engagement in Medicines Development.Therapeutic innovation & regulatory science · 2017Article
- Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.International orthopaedics · 2016Observational
- It's a long shot, but it just might work! Perspectives on the future of medicine.BMC medicine · 2016Article
- Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine.BMC medical ethics · 2016Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.